Birmingham researchers funded by Cancer Research UK and liquid biopsy company Nonacus have developed a new urine test for bladder cancer, which could reduce the need for invasive and time-consuming ...

Early detection of bladder cancer can improve clinical outcomes and survival rates, similar to other cancers. One current area of research involves looking at cell mutations in areas where cancer may ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Valar Labs, the developer of computational histology AI tests for predicting response to cancer therapies, announced new data today which is being presented on ...

Valar Labs’ Vesta Bladder Risk Stratify Dx has secured breakthrough device designation from the US Food and Drug Administration (FDA), becoming the first artificial intelligence (AI)-based digital ...

Under the commercial agreement, A. Menarini Diagnostics will assume exclusive marketing of the non-invasive Bladder EpiCheck® test in Europe in the months ahead, providing patients and clinicians with ...

Five hospitals in England and Wales have switched to urine test, rather than invasive hospital procedure NHS hospitals are using a new way of diagnosing bladder cancer that is faster, more accurate ...